Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2015

01-04-2015 | Endocrine Tumors

Navigating the Management of Follicular Variant Papillary Thyroid Carcinoma Subtypes: A Classic PTC Comparison

Authors: Brendan M. Finnerty, MD, David A. Kleiman, MD, Theresa Scognamiglio, MD, Anna Aronova, MD, Toni Beninato, MD, Thomas J. Fahey III, MD, Rasa Zarnegar, MD

Published in: Annals of Surgical Oncology | Issue 4/2015

Login to get access

Abstract

Background

There are three subtypes of follicular variant papillary thyroid carcinoma (fvPTC): completely encapsulated, well circumscribed, and infiltrative. While infiltrative tumors are more aggressive than completely encapsulated, controversy exists regarding management of fvPTC subtypes. We compared the clinicopathologic features of fvPTC subtypes to those of classic PTC (cPTC) to help guide fvPTC management, using cPTC as a reference.

Methods

A retrospective review was performed on 316 patients with PTC treated at a single institution from 2004 to 2011. There were 197 cPTC and 119 fvPTC tumors, including completely encapsulated (n = 46), well circumscribed (n = 46), and infiltrative (n = 27). Clinicopathologic data were compared between groups.

Results

fvPTC patients had larger tumors than cPTC patients (1.6 cm vs. 1.2 cm, p = 0.001), but age, sex, and family history did not differ. Thirty-one percent of cPTC tumors had extrathyroidal extension compared to 0 % of completely encapsulated, 0 % of well-circumscribed, and 52 % of infiltrative fvPTC tumors (p < 0.05). Central lymph node metastasis occurred in 50 % of cPTC compared to 0 % in completely encapsulated, 20 % in well-circumscribed, and 72 % in infiltrative fvPTC tumors (p < 0.05). Notably, lymph node metastasis was significantly lower in completely encapsulated than in well-circumscribed tumors, without a difference in the median number of nodes sampled. There were no differences in lymphovascular invasion or extranodal extension.

Conclusions

Like cPTC tumors, infiltrative fvPTC tumors have aggressive clinicopathologic features and thus should be treated similarly. Conversely, completely encapsulated and well-circumscribed tumors have less aggressive features compared to cPTC and are more self-limiting; however, well-circumscribed tumors still have a notable incidence of lymph node metastasis. Clinicians should consider this variability in their management algorithm for fvPTC.
Literature
1.
go back to reference Hundahl S, Cady B, Cunningham M, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89:202–17.CrossRefPubMed Hundahl S, Cady B, Cunningham M, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89:202–17.CrossRefPubMed
2.
go back to reference Hundahl S A, Fleming ID, Fremgen A M, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer. 1998;83:2638–48.CrossRefPubMed Hundahl S A, Fleming ID, Fremgen A M, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer. 1998;83:2638–48.CrossRefPubMed
3.
go back to reference Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery. 2003;134:1005–11.CrossRefPubMed Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery. 2003;134:1005–11.CrossRefPubMed
4.
go back to reference Lam AKY, Lo CY, Lam KSL. Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol. 2005;16:323–30.CrossRefPubMed Lam AKY, Lo CY, Lam KSL. Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol. 2005;16:323–30.CrossRefPubMed
5.
go back to reference Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–28.CrossRefPubMed Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–28.CrossRefPubMed
6.
go back to reference Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994;73:424–31.CrossRefPubMed Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994;73:424–31.CrossRefPubMed
7.
go back to reference Chem KT, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1977;1:123–30.CrossRefPubMed Chem KT, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1977;1:123–30.CrossRefPubMed
8.
go back to reference Goodell WM, Saboorian MH, Ashfaq R. Fine-needle aspiration diagnosis of the follicular variant of papillary carcinoma. Cancer. 1998;84:349–54.CrossRefPubMed Goodell WM, Saboorian MH, Ashfaq R. Fine-needle aspiration diagnosis of the follicular variant of papillary carcinoma. Cancer. 1998;84:349–54.CrossRefPubMed
9.
go back to reference Wu HHJ, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262–6.CrossRefPubMed Wu HHJ, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262–6.CrossRefPubMed
10.
go back to reference Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol. 2011;40:69–73.CrossRef Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol. 2011;40:69–73.CrossRef
11.
go back to reference Lin HS, Komisar A, Opher E, Blaugrund SM. Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope. 2000;110:1431–6.CrossRefPubMed Lin HS, Komisar A, Opher E, Blaugrund SM. Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope. 2000;110:1431–6.CrossRefPubMed
12.
go back to reference Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2012;138:227–33.CrossRefPubMed Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2012;138:227–33.CrossRefPubMed
13.
go back to reference Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107:1255–64.CrossRefPubMed Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107:1255–64.CrossRefPubMed
14.
go back to reference Vivero M, Kraft S, Barletta J. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:273–9.CrossRefPubMed Vivero M, Kraft S, Barletta J. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:273–9.CrossRefPubMed
15.
go back to reference Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003;97:1181–5.CrossRefPubMed Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003;97:1181–5.CrossRefPubMed
16.
go back to reference Lang BHH, Lo CY, Chan WF, Lam AKY, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30:752–8.CrossRefPubMed Lang BHH, Lo CY, Chan WF, Lam AKY, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30:752–8.CrossRefPubMed
17.
go back to reference Lin HW, Bhattacharyya N. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival. Laryngoscope. 2010;120:712–6.CrossRefPubMed Lin HW, Bhattacharyya N. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival. Laryngoscope. 2010;120:712–6.CrossRefPubMed
18.
go back to reference Burningham AR, Krishnan J, Davidson BJ, Ringel MD, Burman KD. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol Head Neck Surg. 2005;132:840–4.CrossRefPubMed Burningham AR, Krishnan J, Davidson BJ, Ringel MD, Burman KD. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol Head Neck Surg. 2005;132:840–4.CrossRefPubMed
19.
go back to reference Passler C, Prager G, Scheuba C, Niederle B, Kaserer K, Zettinig G. Follicular variant of papillary thyroid carcinoma. Arch Surg. 2003;138:1362–6.CrossRefPubMed Passler C, Prager G, Scheuba C, Niederle B, Kaserer K, Zettinig G. Follicular variant of papillary thyroid carcinoma. Arch Surg. 2003;138:1362–6.CrossRefPubMed
20.
go back to reference Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009;19:119–27.CrossRefPubMed Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009;19:119–27.CrossRefPubMed
21.
go back to reference Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.PubMedCentralPubMed Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.PubMedCentralPubMed
22.
go back to reference Schneider D, Elfenbein D, Lloyd R, Chen H, Sippel R. Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol. In press. Schneider D, Elfenbein D, Lloyd R, Chen H, Sippel R. Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol. In press.
23.
go back to reference Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin J A, Ghossein R A. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23:1191–200.CrossRefPubMed Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin J A, Ghossein R A. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23:1191–200.CrossRefPubMed
24.
go back to reference Howitt BE, Jia Y, Sholl LM, Barletta J. Molecular alterations in partially-encapsulated/well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:1256–62.CrossRefPubMed Howitt BE, Jia Y, Sholl LM, Barletta J. Molecular alterations in partially-encapsulated/well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:1256–62.CrossRefPubMed
Metadata
Title
Navigating the Management of Follicular Variant Papillary Thyroid Carcinoma Subtypes: A Classic PTC Comparison
Authors
Brendan M. Finnerty, MD
David A. Kleiman, MD
Theresa Scognamiglio, MD
Anna Aronova, MD
Toni Beninato, MD
Thomas J. Fahey III, MD
Rasa Zarnegar, MD
Publication date
01-04-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 4/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4126-3

Other articles of this Issue 4/2015

Annals of Surgical Oncology 4/2015 Go to the issue